These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30954460)

  • 21. Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.
    Brady GF; Kwan R; Ulintz PJ; Nguyen P; Bassirian S; Basrur V; Nesvizhskii AI; Loomba R; Omary MB
    Hepatology; 2018 May; 67(5):1710-1725. PubMed ID: 28902428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
    Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
    J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes.
    Krishan S
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S77-81. PubMed ID: 26810159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
    Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
    Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.
    Nishioji K; Mochizuki N; Kobayashi M; Kamaguchi M; Sumida Y; Nishimura T; Yamaguchi K; Kadotani H; Itoh Y
    PLoS One; 2015; 10(10):e0140427. PubMed ID: 26485523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease.
    Nakajima S; Tanaka H; Sawada K; Hayashi H; Hasebe T; Abe M; Hasebe C; Fujiya M; Okumura T
    J Gastroenterol Hepatol; 2018 Jan; 33(1):283-290. PubMed ID: 28497593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy.
    Singh K; Dahiya D; Kaman L; Das A
    Pol Przegl Chir; 2019 Nov; 92(1):18-22. PubMed ID: 32312927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of non-alcoholic fatty liver disease in non-obese and lean individuals.
    Ahadi M; Molooghi K; Masoudifar N; Namdar AB; Vossoughinia H; Farzanehfar M
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1497-1507. PubMed ID: 33217052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
    Hsieh CJ; Wang PW; Hu TH
    PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the
    Perez-Diaz-Del-Campo N; Abete I; Cantero I; Marin-Alejandre BA; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32365683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    Sun MY; Zhang L; Shi SL; Lin JN
    PLoS One; 2016; 11(4):e0154337. PubMed ID: 27128842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipocalin-type prostaglandin D
    Kumar S; Srivastava A; Palaia T; Hall C; Lee J; Stevenson M; Zhao CL; Ragolia L
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106429. PubMed ID: 32145387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population.
    Li Z; Ye CY; Wang L; Li JM; Yang L
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32698306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease.
    Zhu P; Lu H; Jing Y; Zhou H; Ding Y; Wang J; Guo D; Guo Z; Dong C
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):166-175. PubMed ID: 30793973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
    Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
    J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
    Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
    J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.
    Su Y; Liu Z; Yang L; Li Y; Jiang S; Yao H; Du G
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):894-904. PubMed ID: 32505733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.